Annual Interest Expense
$59.30 M
+$26.90 M+83.02%
31 December 2023
Summary:
United Therapeutics annual interest expense is currently $59.30 million, with the most recent change of +$26.90 million (+83.02%) on 31 December 2023. During the last 3 years, it has risen by +$35.80 million (+152.34%). UTHR annual interest expense is now at all-time high.UTHR Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$10.10 M
-$1.50 M-12.93%
30 September 2024
Summary:
United Therapeutics quarterly interest expense is currently $10.10 million, with the most recent change of -$1.50 million (-12.93%) on 30 September 2024. Over the past year, it has dropped by -$5.50 million (-35.26%). UTHR quarterly interest expense is now -35.26% below its all-time high of $15.60 million, reached on 30 September 2023.UTHR Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$50.10 M
-$5.50 M-9.89%
30 September 2024
Summary:
United Therapeutics TTM interest expense is currently $50.10 million, with the most recent change of -$5.50 million (-9.89%) on 30 September 2024. Over the past year, it has dropped by -$6.40 million (-11.33%). UTHR TTM interest expense is now -15.51% below its all-time high of $59.30 million, reached on 31 December 2023.UTHR TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +83.0% | -35.3% | -11.3% |
| 3 y3 years | +152.3% | +119.6% | +167.9% |
| 5 y5 years | +326.6% | -13.7% | +30.1% |
UTHR Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +218.8% | -35.3% | +119.6% | -15.5% | +169.3% |
| 5 y | 5 years | at high | +326.6% | -35.3% | +119.6% | -15.5% | +169.3% |
| alltime | all time | at high | +2626.4% | -35.3% | +1920.0% | -15.5% | +2177.3% |
United Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.10 M(-12.9%) | $50.10 M(-9.9%) |
| June 2024 | - | $11.60 M(-12.8%) | $55.60 M(-5.4%) |
| Mar 2024 | - | $13.30 M(-11.9%) | $58.80 M(-0.8%) |
| Dec 2023 | $59.30 M(+83.0%) | $15.10 M(-3.2%) | $59.30 M(+5.0%) |
| Sept 2023 | - | $15.60 M(+5.4%) | $56.50 M(+12.8%) |
| June 2023 | - | $14.80 M(+7.2%) | $50.10 M(+20.7%) |
| Mar 2023 | - | $13.80 M(+12.2%) | $41.50 M(+28.1%) |
| Dec 2022 | $32.40 M(+74.2%) | $12.30 M(+33.7%) | $32.40 M(+30.6%) |
| Sept 2022 | - | $9.20 M(+48.4%) | $24.80 M(+22.8%) |
| June 2022 | - | $6.20 M(+31.9%) | $20.20 M(+8.0%) |
| Mar 2022 | - | $4.70 M(0.0%) | $18.70 M(+0.5%) |
| Dec 2021 | $18.60 M(-20.9%) | $4.70 M(+2.2%) | $18.60 M(-0.5%) |
| Sept 2021 | - | $4.60 M(-2.1%) | $18.70 M(-1.6%) |
| June 2021 | - | $4.70 M(+2.2%) | $19.00 M(-4.5%) |
| Mar 2021 | - | $4.60 M(-4.2%) | $19.90 M(-15.3%) |
| Dec 2020 | $23.50 M(-46.8%) | $4.80 M(-2.0%) | $23.50 M(-18.1%) |
| Sept 2020 | - | $4.90 M(-12.5%) | $28.70 M(-19.2%) |
| June 2020 | - | $5.60 M(-31.7%) | $35.50 M(-15.7%) |
| Mar 2020 | - | $8.20 M(-18.0%) | $42.10 M(-4.8%) |
| Dec 2019 | $44.20 M(+218.0%) | $10.00 M(-14.5%) | $44.20 M(+14.8%) |
| Sept 2019 | - | $11.70 M(-4.1%) | $38.50 M(+24.6%) |
| June 2019 | - | $12.20 M(+18.4%) | $30.90 M(+43.1%) |
| Mar 2019 | - | $10.30 M(+139.5%) | $21.60 M(+55.4%) |
| Dec 2018 | $13.90 M(+54.4%) | $4.30 M(+4.9%) | $13.90 M(+6.1%) |
| Sept 2018 | - | $4.10 M(+41.4%) | $13.10 M(+6.5%) |
| June 2018 | - | $2.90 M(+11.5%) | $12.30 M(+13.9%) |
| Mar 2018 | - | $2.60 M(-25.7%) | $10.80 M(+20.0%) |
| Dec 2017 | $9.00 M(+130.8%) | $3.50 M(+6.1%) | $9.00 M(+16.9%) |
| Sept 2017 | - | $3.30 M(+135.7%) | $7.70 M(+57.1%) |
| June 2017 | - | $1.40 M(+75.0%) | $4.90 M(+19.5%) |
| Mar 2017 | - | $800.00 K(-63.6%) | $4.10 M(+5.1%) |
| Dec 2016 | $3.90 M | $2.20 M(+340.0%) | $3.90 M(+77.3%) |
| Sept 2016 | - | $500.00 K(-16.7%) | $2.20 M(-12.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $600.00 K(0.0%) | $2.50 M(-21.9%) |
| Mar 2016 | - | $600.00 K(+20.0%) | $3.20 M(-31.9%) |
| Dec 2015 | $4.70 M(-73.3%) | $500.00 K(-37.5%) | $4.70 M(-39.2%) |
| Sept 2015 | - | $800.00 K(-38.5%) | $7.74 M(-33.6%) |
| June 2015 | - | $1.30 M(-38.1%) | $11.64 M(-22.8%) |
| Mar 2015 | - | $2.10 M(-40.6%) | $15.09 M(-14.3%) |
| Dec 2014 | $17.60 M(-2.5%) | $3.54 M(-24.9%) | $17.60 M(-5.5%) |
| Sept 2014 | - | $4.71 M(-0.8%) | $18.63 M(+0.9%) |
| June 2014 | - | $4.75 M(+3.0%) | $18.46 M(+1.2%) |
| Mar 2014 | - | $4.61 M(+1.1%) | $18.23 M(+1.0%) |
| Dec 2013 | $18.06 M(+8.5%) | $4.56 M(+0.5%) | $18.06 M(+0.4%) |
| Sept 2013 | - | $4.54 M(+0.4%) | $17.99 M(+0.9%) |
| June 2013 | - | $4.52 M(+1.9%) | $17.83 M(+3.7%) |
| Mar 2013 | - | $4.44 M(-1.2%) | $17.19 M(+3.3%) |
| Dec 2012 | $16.64 M(-22.1%) | $4.49 M(+2.4%) | $16.64 M(-3.6%) |
| Sept 2012 | - | $4.38 M(+13.0%) | $17.26 M(-5.6%) |
| June 2012 | - | $3.88 M(-0.2%) | $18.29 M(-7.8%) |
| Mar 2012 | - | $3.89 M(-24.0%) | $19.84 M(-7.1%) |
| Dec 2011 | $21.37 M(+8.4%) | $5.11 M(-5.6%) | $21.37 M(-1.6%) |
| Sept 2011 | - | $5.42 M(-0.3%) | $21.71 M(+2.9%) |
| June 2011 | - | $5.43 M(+0.4%) | $21.11 M(+3.3%) |
| Mar 2011 | - | $5.41 M(-0.8%) | $20.43 M(+3.7%) |
| Dec 2010 | $19.71 M(+53.1%) | $5.46 M(+13.4%) | $19.71 M(+10.0%) |
| Sept 2010 | - | $4.81 M(+1.1%) | $17.91 M(+9.0%) |
| June 2010 | - | $4.76 M(+1.5%) | $16.44 M(+10.1%) |
| Mar 2010 | - | $4.69 M(+28.1%) | $14.93 M(+15.9%) |
| Dec 2009 | $12.88 M(+12.6%) | $3.66 M(+9.8%) | $12.88 M(+9.6%) |
| Sept 2009 | - | $3.33 M(+2.6%) | $11.75 M(+6.4%) |
| June 2009 | - | $3.25 M(+23.2%) | $11.04 M(+41.7%) |
| Mar 2009 | - | $2.64 M(+4.2%) | $7.79 M(+51.2%) |
| Dec 2008 | $11.44 M(+425.9%) | $2.53 M(-3.6%) | $5.15 M(+96.4%) |
| Sept 2008 | - | $2.62 M | $2.62 M |
| Dec 2007 | $2.17 M | - | - |
FAQ
- What is United Therapeutics annual interest expense?
- What is the all time high annual interest expense for United Therapeutics?
- What is United Therapeutics annual interest expense year-on-year change?
- What is United Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for United Therapeutics?
- What is United Therapeutics quarterly interest expense year-on-year change?
- What is United Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for United Therapeutics?
- What is United Therapeutics TTM interest expense year-on-year change?
What is United Therapeutics annual interest expense?
The current annual interest expense of UTHR is $59.30 M
What is the all time high annual interest expense for United Therapeutics?
United Therapeutics all-time high annual interest expense is $59.30 M
What is United Therapeutics annual interest expense year-on-year change?
Over the past year, UTHR annual interest expense has changed by +$26.90 M (+83.02%)
What is United Therapeutics quarterly interest expense?
The current quarterly interest expense of UTHR is $10.10 M
What is the all time high quarterly interest expense for United Therapeutics?
United Therapeutics all-time high quarterly interest expense is $15.60 M
What is United Therapeutics quarterly interest expense year-on-year change?
Over the past year, UTHR quarterly interest expense has changed by -$5.50 M (-35.26%)
What is United Therapeutics TTM interest expense?
The current TTM interest expense of UTHR is $50.10 M
What is the all time high TTM interest expense for United Therapeutics?
United Therapeutics all-time high TTM interest expense is $59.30 M
What is United Therapeutics TTM interest expense year-on-year change?
Over the past year, UTHR TTM interest expense has changed by -$6.40 M (-11.33%)